-------------------------------------------------------------------------------
U.S. Securities and Exchange Commission
Washington, D.C. 20549
--------------------------
Form 10-K
(Mark One)
[ X ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2003
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission File No. 0-10634
---------------------------
Nevada Chemicals, Inc.
(Exact name of registrant as specified in its charter)
Utah 87-0351702
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
9149 So. Monroe Plaza Way, Suite B
Sandy, Utah 84070
(Address of principal executive offices, zip code)
Registrant's telephone number, including area code: (801) 984-0228
---------------------------
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Title of class
--------------
Common Stock, $0.001 Par Value
---------------------------
Check whether the Registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes [ X ] No [ ]
Check if disclosure of delinquent filers pursuant to Item 405 of
Regulation S-K is not contained herein, and will not be contained, to the best
of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [ ]
Based on the closing sales price of June 30, 2003, the aggregate market
value of the Common Stock held by non-affiliates was $13,467,260 (3,507,099
shares estimated to be held by non-affiliates). Shares of the Common Stock
controlled by each officer and director and by each person who may be deemed to
be an affiliate of the registrant have been excluded.
Indicate by check mark whether the Registrant is an accelerated filer
(as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [ X ]
The number of shares outstanding of the registrant's par value $0.001 Common
Stock as of March 1, 2004 was 6,807,919.
Nevada Chemicals, Inc.
Annual Report on Form 10-K
Table of Contents
Part I Page No.
Item 1. Business 1
Item 2. Properties 3
Item 3. Legal Proceedings 3
Item 4. Submission of Matters to a Vote of Security Holders 3
Part II
Item 5. Market for the Registrant's Common Equity, Related
Stockholder Matters and Issuer Purchases of Equity
Securities 4
Item 6. Selected Financial Data 6
Item 7. Management's Discussion and Analysis of Financial
Condition and Results of Operations 7
Item 7A. Quantitative and Qualitative Disclosure about Market Risk 11
Item 8. Financial Statements and Supplementary Data 11
Item 9. Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure 11
Item 9A. Controls and Procedures 11
Part III
Item 10. Directors and Executive Officers of the Registrant 12
Item 11. Executive Compensation 12
Item 12. Security Ownership of Certain Beneficial Owners and
Management 12
Item 13. Certain Relationships and Related Transactions 12
Item 14. Principal Accountant Fees and Services 12
Part IV
Item 15. Exhibits, Financial Statement Schedules, and Reports on
Form 8-K 13
Signatures 15
PART I
Item 1. Business
General
Nevada Chemicals, Inc., a Utah corporation organized in 1979 (the
"Company"), supplies chemicals to the gold mining industry in the western United
States, primarily through its ownership in Cyanco Company ("Cyanco"), operations
considered to be in one business segment. Winnemucca Chemicals, Inc.
("Winnemucca Chemicals"), a wholly owned subsidiary of the Company, has a 50%
interest in Cyanco, a non-corporate joint venture engaged in the manufacture and
sale of liquid sodium cyanide.
In November 2001, the Company closed the sale of the assets,
subsidiaries and certain joint venture interests of its explosives business (the
"Explosives Business") to Union Espanola de Explosivos S.A. and certain of its
subsidiaries ("UEE"). In connection with this transaction, the name of the
Company was changed from Mining Services International Corporation to Nevada
Chemicals, Inc.
The Company's operating revenues consist mainly of earnings from Cyanco
based on the equity method of accounting and management fee income from Cyanco.
In addition to income from Cyanco operations, the Company earned investment
income during 2003 on the Company's cash and cash equivalents and short-term
investments.
Cyanco Joint Venture Interest
Cyanco is a 50/50 joint venture between the Company and Degussa
Corporation, a wholly owned subsidiary of Degussa A.G., a German company
("Degussa"). Cyanco produces and markets liquid sodium cyanide from its
Winnemucca, Nevada plant. Cyanco services the western U.S. gold mining industry,
primarily located in Nevada, selling sodium cyanide for use in leaching precious
metals in mining operations. There are principally two types of products
marketed to gold mines for the leaching process: (1) a solid "briquette" sodium
cyanide product which requires handling and physical dissolution before use, and
(2) the type provided by Cyanco, a liquid sodium cyanide which provides for
greater personal and environmental safety and comes to the mining customer ready
to use. The manufacturing cost for the liquid product is lower than for solid
product when drying, handling, re-dissolution and chemical adjustment costs at
the mine site are taken into account.
Since the liquid product is shipped by truck from the plant to the mine
site in a solution of about 30% sodium cyanide and 70% water, freight costs for
liquid sodium cyanide are significant and shipping must be managed carefully,
both in terms of cost and safety and environmental protection. Cyanco has a
contract for this service with an Omaha, Nebraska company that utilizes
dedicated equipment specifically designed for Cyanco. The transportation
equipment includes trucks equipped with linked satellite communication systems
for security purposes.
With the 1998 addition of a second production unit, Cyanco has an
annual liquid sodium cyanide production capacity of approximately 85 million
pounds.
Demand for the sodium cyanide manufactured by Cyanco is dependent on
the level of gold mining activity it services. The level of gold mining activity
is dependent to some extent on the price of gold. Over the past five years, the
market price of gold has generally increased from a low of $252 per ounce on
July 20, 1999 to as high as $425 per ounce on January 13, 2004. Since then, the
price of gold has pulled back to $393 per ounce on March 2, 2004. If the price
of gold continues at these higher values, the gold mining community may be
induced to expand exploration and production activities. In such event, gold
production in Cyanco's market area should remain relatively stable or possibly
increase in the foreseeable future.
1
Competition and Purchase of FMC Sodium Cyanide Business
Cyanco historically represented one of three sources of sodium cyanide
in the western United States. The world market for briquette or dry-form sodium
cyanide is dominated by E.I. DuPont Nemours ("DuPont"). Domestically, Cyanco
competed with DuPont and also with FMC Corporation ("FMC"), which marketed and
delivered liquid sodium cyanide in the same geographic area as Cyanco.
Effective April 1, 2002, Cyanco purchased the commercial and certain
distribution assets related to FMC's sodium cyanide business. As a result of
this transaction, FMC exited the business, ending its 12-year role as a supplier
of sodium cyanide to the Nevada gold mining industry. Cyanco assumed FMC's
on-going contractual obligations under its existing sodium cyanide contracts and
began supplying these customers in April 2002. The FMC supply contracts acquired
by Cyanco are with several key Nevada gold mining operations. According to
Cyanco estimates, the business purchased represents approximately 25,000 tons of
additional sodium cyanide business for Cyanco during the lifetime of the
contracts, which vary from approximately four years to the life of certain gold
mines. In addition to the transferred contracts, Cyanco purchased certain
equipment including distribution tank trailers and storage tanks.
As a result of the FMC transaction, Cyanco competes primarily with
DuPont to supply sodium cyanide to the Nevada gold mining industry. The Company
believes that the important competitive factors in the sodium cyanide market are
location, service and quality. However, as gold prices fluctuate, the price of
sodium cyanide has become a significant competitive factor. Cyanco has had to
meet competitive demands, and has been able to achieve results by being creative
and service-oriented and offering competitive pricing.
Dependence on Customers
All of the Company's sales occur within the Western United States.
Since most of Cyanco's cyanide customers are large mining companies, the number
of companies it services is relatively small compared to those of a wholesale
distribution or retail business. A loss of one or more customers could adversely
affect future sales, and may cause a material adverse effect on the Company's
results of operations. Such a loss can occur either from the customer switching
to another source or from the customer electing to close or suspend a mining
operation. However, such losses are not currently expected to occur, since these
customers have lower than average operating costs to produce gold, which should
allow them to continue producing gold in periods of fluctuating market prices of
gold.
Patents, Trademarks and Licenses
In March 1989, Cyanco obtained from Mitsubishi Gas Chemical Company,
Inc., a Japanese corporation, in consideration for payment of a one-time license
fee, a perpetual license for a patented process and related technical
information covering the manufacture of hydrogen cyanide for use in the
manufacture of liquid sodium cyanide at the Cyanco plant. The license is a
nonexclusive, nonsublicensable and nontransferable right to use the technology
at the Cyanco plant, and is materially important to the plant's operation. The
Company's historical research and development expenditures were primarily
related to the discontinued Explosives Business. However, the Company developed
a patent issued during 2000 for the production and transportation of a
"wet-cake" cyanide product which may be used by Cyanco in expanding its
freight-logical market. The Company does not currently have any significant
research and development activities, and there has not been any
customer-sponsored research and development.
Raw Materials
Cyanco has historically not experienced significant difficulty in
obtaining necessary raw materials used in the manufacture of its products. In
the present environment, raw material availability could be impacted for short
periods of time, but Cyanco does not expect significant difficulty in obtaining
raw materials for the longer term. Cyanco must compete with other markets for a
major portion of its raw materials (ammonia, caustic soda, natural gas and
2
electricity). The supplies of these products have been adequate in past years to
meet the needs of industrial as well as agricultural and other commercial users.
Cyanco has historically entered into long-term contracts for transportation of
natural gas to the Cyanco facility. Cyanco has not had significant difficulty in
obtaining the other necessary raw materials since there are alternative sources
of supply. Cyanco has experienced, however, wide fluctuations in the cost of raw
materials driven by the cost of natural gas, which in turn impacts the price and
availability of ammonia and caustic soda. It is Cyanco's intent wherever
possible to continue to pass short-term raw material price fluctuations on to
its client base in order to maintain profitability. However, not all of the
supply relationships include such cost sharing provisions.
Employees
The Company currently employs two individuals and one part-time
consultant at its corporate offices. Cyanco has 29 employees at its plant in
Winnemucca, Nevada. The Company and Cyanco consider relations with their
employees to be positive.
Environmental Compliance
Cyanco is subject to federal, state and local laws regulating the
protection of the environment in the handling, storage and shipment of sodium
cyanide and related raw materials. In preparation for the manufacture and sale
of liquid sodium cyanide at the Cyanco plant, Cyanco incurred material capital
expenditures relating to compliance with environmental laws and regulations,
including expenditures required for specialty trucks and tankers and development
of an emergency response plan in the event of a hazardous materials spill.
Cyanco's processes are designed such that no liquid discharge is created during
the manufacture of its product. Compliance with such laws, rules and regulations
on an ongoing basis is not expected to require additional material capital
expenditures in the short-term. Recently Cyanco has reviewed and increased
security measures in light of potential terrorist activities at chemical
facilities.
Other Governmental Regulations
Cyanco is subject to various governmental authorities with respect to
transportation and handling of hazardous materials. In addition, it is subject
to OSHA's Process Safety Management program at the Winnemucca plant. Cyanco has
implemented compliance programs, which the Company believes addresses the
program objectives and guidelines. Cyanco is regularly inspected by Nevada's
regulatory agencies to monitor compliance to Nevada's Chemical Accident
Prevention Program (CAPP).
Item 2. Properties
The Company currently leases office facilities comprised of 1,325
square feet and located at 9149 South Monroe Plaza Way, Sandy, Utah under a
one-year lease agreement.
Cyanco owns its property, consisting of approximately 1,300 acres of
land and manufacturing facilities near Winnemucca, Nevada.
Item 3. Legal Proceedings
The Company is not a party to any legal proceedings.
Item 4. Submission of Matters to a Vote of Security Holders
There were no matters submitted to a vote of security holders during
the fourth quarter of 2003.
3
PART II
Item 5: Market for the Registrant's Common Equity, Related Stockholder
Matters and Issuer Purchases of Equity Securities
(a) Price Range of Common Stock
The common stock of the Company is currently listed on the Nasdaq
National Market ("NNM"), under the symbol "NCEM." The following table sets forth
the approximate range of high and low closing prices for the common stock of the
Company during the periods indicated. The quotations presented reflect
inter-dealer prices, without retail markup, markdown, or commissions, and may
not necessarily represent actual transactions in the common stock.
Closing Prices
--------------
High Low
---- ---
2002 First Quarter $2.50 $1.30
Second Quarter $4.00 $2.35
Third Quarter $3.15 $2.65
Fourth Quarter $3.39 $2.45
2003 First Quarter $3.62 $2.85
Second Quarter $3.95 $3.02
Third Quarter $4.48 $3.60
Fourth Quarter $5.77 $4.21
On March 1, 2004, the closing quotation for the common stock on NNM was
$5.00 per share. As reflected by the high and low prices on the foregoing table,
the trading price of the Common Stock of the Company can be volatile with
dramatic changes over short periods. The trading price may reflect imbalances in
the supply and demand for shares of the Company, market reaction to perceived
changes in the industry in which the Company sells products and services,
fluctuations in the price of gold, general economic conditions, and other
factors. Investors are cautioned that the trading price of the common stock can
change dramatically based on changing market perceptions that may be unrelated
to the Company and its activities.
(b) Approximate number of equity security holders
The approximate number of record holders of the Company's Common Stock
as of March 1, 2004 was 470, which does not include shareholders whose stock is
held through securities position listings.
(c) Dividends
During 2003, the Company declared dividends of $.05 per share on a
total of 6,807,919 outstanding shares for each of the second, third and fourth
calendar quarters, for an aggregate dividend of approximately $1,021,000 during
2003. The dividends for the second and third quarters were paid in cash, with
dividends payable of $341,000 for the fourth quarter included in accounts
payable and accrued expenses in the Company's consolidated balance sheet at
December 31, 2003. These dividends payable were paid in January 2004. Payment of
dividends is within the discretion of the Company's Board of Directors and there
are no material restrictions that limit the Company's ability to pay dividends
on the Common Stock. The Company paid no cash dividends during 2002.
4
(d) Securities authorized for issuance under equity compensation plans
The Company does not have any equity compensation plans that have not
been approved by its shareholders. Under the Company's 1988 Non-Qualified Stock
Option Plan (the "Option Plan"), as amended, a maximum of 1,315,130 common
shares were made available for granting of options to purchase common stock. The
Option Plan, and subsequent material amendments or additions to shares available
for granting options, were previously approved by the shareholders of the
Company. The following table presents information concerning the Option Plan.
Number of Securities
Remaining Available for
Future Issuance Under
Number of Securities Weighted-Average Equity Compensation Plans
to be Issued Upon Exercise Exercise Price of (Excluding Securities Reflected
Plan Category of Outstanding Options Outstanding Options in Column (a))
- ------------------------------------------------------------------------------------------------------------------
(a) (b) (c)
Equity compensation plans
approved by security
holders 208,500 $1.34 614,207
See also Note 10 of the Notes to Consolidated Financial Statements for further
information regarding the Option Plan.
During 2003, the Company did not sell any of its equity securities.
During the fourth quarter of 2003, neither the Company nor any of its
affiliates purchased any equity securities of the Company.
5
Item 6. Selected Financial Data
The following consolidated selected financial data as of and for each
of the fiscal years in the five year period ended December 31, 2003 were derived
from audited financial statements of the Company and its consolidated
subsidiaries. The financial statements as of and for each of the fiscal years in
the five year period were audited by Tanner + Co., independent public
accountants. The data set forth below should be read in conjunction with the
"Management's Discussion and Analysis of Financial Condition and Results of
Operations" and the Company's Consolidated Financial Statements and related
Notes thereto.
Years Ended December 31,
2003 2002 2001 2000 1999
-------------------------------------------------------
(in thousands except per share amounts)
Results of Operations Data (1):
Operating revenues and equity in earnings (2) $ 2,960 $ 3,912 $ 2,533 $ 2,066 $ 2,880
Income from continuing
operations before extraordinary
item 1,705 2,128 1,007 795 817
Extraordinary item-extinguishment of debt - - - - 1,599
Income (loss) from discontinued
operations - - (821) (4,826) (1,691)
Net income (loss) 1,705 2,128 186 (4,301) 725
Earnings (loss) per common
share - diluted:
Income from continuing
operations before extraordinary
item $ 0.24 $ 0.29 $ 0.14 $ 0.11 $ 0.11
Extraordinary item - - - - 0.22
Income (loss) from discontinued
operations - - (0.11) (0.66) (0.23)
Net income (loss) 0.24 0.29 0.03 (0.55) 0.10
Cash dividends declared per
per common share $ 0.15 $ - $ - $ - $ 0.025
Balance Sheet Data:
Total Assets $25,264 $24,692 $23,661 $22,590 $ 29,986
Long-term debt - - - - -
Stockholders' equity 21,897 22,011 20,314 20,245 24,351
(1) The sale of the Explosives Business in 2001 is accounted for as a
discontinued operation, and accordingly, amounts in the financial statements
and related notes for all periods have been restated to reflect discontinued
operations accounting, including offsetting long-term debt and other
liabilities assumed in the sale against the net assets sold on the consolidated
balance sheets.
(2) Includes the Company's 50% share of the operating results of Cyanco reported
using the equity method of accounting.
6
Item 7. Management's Discussion and Analysis of Financial Condition
and Results of Operations
Overview
On November 8, 2001, the shareholders of the Company approved the sale
of the Explosives Business pursuant to an Asset Purchase Agreement between the
Company and UEE. The Company entered into the agreement on November 30, 2000 and
consummated the sale on November 15, 2001. The sale of the Explosives Business
is accounted for as a discontinued operation, and accordingly, the operating
results for the Explosives Business in the accompanying financial statements for
the years ended December 31, 2001 have been presented as discontinued
operations.
Continuing operations reported in the statements of operations for all
periods presented consist primarily of the Company's proportionate share of the
operating results from its 50% interest in Cyanco, management fee income from
Cyanco, investment income on cash and cash equivalents and short-term
investments, and corporate overhead, costs and expenses. Since the Company does
not own more than 50% of Cyanco, the financial statements of Cyanco are not
consolidated with the financial statements of the Company. Summarized financial
information for Cyanco for the years ended December 31, 2003, 2002 and 2001 is
presented in Note 11 to the Company's consolidated financial statements.
Separate audited financial statements of Cyanco are included in this report as
Exhibit 99.1.
Effective April 1, 2002, Cyanco purchased the commercial and certain
distribution assets related to FMC's sodium cyanide business. As a result of
this transaction, FMC exited the business, ending its role as a supplier of
sodium cyanide to the Nevada gold mining industry. Cyanco assumed FMC's on-going
contractual obligations under its existing sodium cyanide contracts and began
supplying these customers in April 2002. In addition to the transferred
contracts, Cyanco purchased certain equipment including distribution tank
trailers and storage tanks.
The following discussion of results of operations includes only
continuing operations. For discussions of historical results of operations of
the discontinued explosives business, refer to the Company's previous annual or
quarterly filings for 2001 and prior years.
Results of Operations
2003 vs. 2002
Equity in earnings of Cyanco decreased $807,000, or 24%, in 2003
compared to 2002. Cyanco revenues decreased $487,000, or 2%, in 2003 compared to
2002. The decrease in revenues is due to two factors: (1) lower volumes in the
current year resulting from market pressures and (2) certain customers
decreasing purchases during scheduled maintenance of mining facilities in 2003.
These decreases in revenues from lower volumes of product sold were partially
offset by the ability of the Company to increase sales prices for certain
customers with cost plus pricing arrangements, and from the additional volume of
sodium cyanide supplied by Cyanco to customers under contracts acquired from FMC
in April 2002. Cyanco costs and expenses increased $1,129,000, or 5%, in 2003
compared to 2002, primarily due to the increase in certain key raw material
costs compared to last year. As a result, Cyanco net income before taxes
decreased $1,616,000 or 24%, during 2003 compared to 2002.
Management fee revenue from Cyanco decreased to $451,000 in 2003
compared to $460,000 in 2002 due to the decreased revenues of Cyanco.
Other operating revenues decreased to $0 in 2003 compared to $136,000
in 2002. The decrease is due to elimination of rental income as a result of the
sale of the Company's office building in November 2002.
7
Investment and other income increased to $302,000 in 2003 compared to
$270,000 in 2002. The increase in investment earnings is attributable to higher
average balances in cash equivalents and short-term investments in 2003 compared
to 2002, and to an improvement in the rate of return on investments due to
increased diversification of investment securities in 2003.
The Company realized a total gain on the sale of assets of $680,000 in
2002, of which $220,000 related to the sale of the office building and $460,000
related to the Company's share of proceeds from the sale of the assets of the
Company's joint venture in West Africa. The Company had no sales of assets in
2003.
General and administrative expenses decreased $617,000 or 49%, in 2003
compared to 2002. This decrease is due primarily to certain significant
non-recurring expenses in 2002. In 2002, the Company incurred $206,000 of
compensation expense to two members of the board of directors, $103,000 each for
services and the directors' surrender of all their outstanding stock options.
Also, an additional $214,000 in bad debt expense was recorded in 2002 related to
net notes and accounts receivable estimated to be uncollectible by UEE that were
assigned back to the Company by UEE pursuant to the terms of the agreement to
sell the Explosives Business. The Company continues to pursue collection of the
assigned receivables. During 2003, the Company recovered $70,000 of the
receivables, which was recorded as an offset to general and administrative
expenses. In addition, $62,000 of the decrease in 2003 is due to the elimination
of operating expenses and depreciation expense associated with the office
building sold in November 2002.
2002 vs. 2001
Equity in earnings of Cyanco increased $1,253,000, or 61%, in 2002
compared to 2001. Cyanco revenues increased $865,000, or 3%, in 2002 compared to
2001. The increase in Cyanco revenues is due primarily to the additional volume
of sodium cyanide supplied by Cyanco to customers under contracts acquired from
FMC and increased sales to existing customers in response to increased mining
activity resulting from higher prices of gold. The increase in revenues was
tempered somewhat by lower sales prices to some customers due to market
pressures and to certain contracts containing cost plus pricing, since the cost
of certain key raw materials decreased from levels experienced in 2001. Even
with the increase in revenues and resultant production increases, Cyanco costs
and expenses decreased $1,641,000, or 6% in 2002 compared to 2001. The decrease
in operating costs resulted primarily from improvement in variable manufacturing
costs as the cost of certain key raw materials decreased. As a result, Cyanco
net income before taxes increased $2,506,000, or 61% during 2002 compared to
2001.
Management fee revenue from Cyanco increased to $460,000 in 2002
compared to $443,000 in 2001 due to the increased revenues of Cyanco.
Other operating revenues increased to $136,000 in 2002 compared to
$27,000 in 2001. The increase is attributable to rental income from an office
building owned by the Company that commenced in November 2001. The office
building was sold in November 2002.
Investment and other income increased to $270,000 in 2002 compared to
$86,000 in 2001. The increase in investment earnings is attributable to higher
average balances in cash equivalents and short-term investments in 2002 compared
to 2001 due to the investment of proceeds received from the sale of the
Explosives Business, the sale of the Company's office building and the sale of
the assets of the Company's joint venture in West Africa.
The Company realized a total gain on the sale of assets of $680,000 in
2002, of which $220,000 related to the sale of the office building and $460,000
related to the Company's share of proceeds from the sale of the assets of the
Company's joint venture in West Africa. No such sales of assets, other than
those of the discontinued Explosives Business, occurred in 2001.
General and administrative expenses increased $241,000 or 24%, in 2002
compared to 2001. This increase is due primarily to $206,000 of compensation
expense incurred in 2002 to two members of the Company's Board of Directors,
$103,000 each for services and the directors' surrender of all their outstanding
8
stock options. Also, an additional $214,000 in bad debt expense was recorded in
2002 related to net notes and accounts receivable estimated to be uncollectible
by UEE that were assigned back to the Company by UEE pursuant to the terms of
the agreement to sell the Explosives Business. The Company continues to pursue
collection of the assigned receivables.
Liquidity and Capital Resources
As part of the purchase of the Explosives Business in November 2001,
UEE assumed all long-term debt of the Company. During 2003 and 2002, the Company
incurred no new long-term debt. Therefore, at December 31, 2003, the liabilities
of the Company consisted only of current liabilities of $1,635,000 and deferred
income taxes payable of $1,732,000. Current liabilities at December 31, 2003
consisted of trade accounts payable of $15,000, dividends payable of $341,000
and accrued expenses (comprised primarily of accrued income taxes) of
$1,279,000. These current liabilities compare favorably to total current assets
of $12,393,000 at December 31, 2003. Current assets were comprised primarily of
cash and cash equivalents of $6,424,000 and short-term investments that are
available for sale of $5,614,000.
Cash in excess of short-term operating needs has been invested
primarily in a variety of interest bearing investment accounts with maturities
ranging from 30 days to one year. The board of directors of the Company is
currently evaluating alternative uses for the cash of the Company, including
optimizing short-term investment results, diversification of the Company's
business, further investment in Cyanco, the payment of dividends to shareholders
and other strategies.
Net cash used in operating activities for 2003 was $(439,000) compared
to net cash used in operating activities of $(1,010,000) for 2002. This decrease
in net cash used in operations is due to the reduction in general and
administrative expenses further discussed above. Because the Company accounts
for its investment in Cyanco using the equity method, equity in earnings of
Cyanco, a non-cash item, is eliminated from operating activities in the
consolidated statements of cash flows, with cash distributions from Cyanco
included in cash flows from investing activities.
Net cash provided by investing activities for 2003 was $1,714,000
compared to net cash provided by investing activities of $1,032,000 for 2002. In
2003, the Company received $3,000,000 in distributions from Cyanco and net
collections of notes receivable from UEE and its subsidiaries of $319,000. These
principal sources of cash from investing activities were offset in 2003 by the
purchase of property and equipment of $(2,000) and the net purchase of
short-term investments of $(1,603,000). In 2002, net cash realized from the sale
of assets, comprised of the Company's office building and assets of its West
Africa joint venture, totaled $1,556,000. The Company also received $3,000,000
in distributions from Cyanco in 2002 and net collections of notes receivable
from UEE and its subsidiaries of $489,000. Cash received from investing
activities in 2002 was partially offset by the net purchase of short-term
investments of $(4,013,000).
Net cash used in financing activities for 2003 was $(1,463,000)
compared to net cash used in financing activities of $(421,000) for 2002. Net
cash used in financing activities in 2003 consisted of $680,000 in dividends for
the second and third quarters, and $783,000 for the purchase and retirement of
treasury stock. During 2003, the Company declared dividends of $.05 per share
for each of the second, third and fourth quarters. The dividend for the fourth
quarter of 2003 of $341,000 was paid in January 2004. The net cash used in
financing activities in 2002 consisted of $(421,000) used to purchase treasury
stock. In November 2001, the Company's Board of Directors authorized a stock
repurchase plan that provides for the purchase of up to 500,000 shares of the
Company's currently issued and outstanding common stock. Purchases under the
stock repurchase plan may be made from time to time at various prices in the
open market, through block trades or otherwise. As part of the stock repurchase
program, the Company purchased and retired 251,224 and 146,797 common shares in
2003 and 2002, respectively.
9
The Company has retained all contingent liabilities relating to an
ongoing audit by the Canada Customs and Revenue Agency ("CCRA") of previously
filed income tax returns in Canada. Todate, CCRA has taken a different position
on certain matters than that taken by the Company. The Company, based on
consultation with its professional tax advisors in Canada, believes that the
facts and circumstances support the position taken by the Company, and continues
discussions and negotiations with CCRA. The Company believes that amounts
accrued and included in income taxes payable at December 31, 2003 will be
adequate for the resolution of the audit by CCRA. However, there can be no
assurance that such costs will not ultimately exceed the current estimate.
The Company considers its cash resources sufficient to meet the
operating needs of its current level of business for the year ending December
31, 2004.
Critical Accounting Policies
Our critical accounting policies include the following:
o Investment in Cyanco
o Discontinued Operations
o Short-Term Investments
Since the Company does not own more than 50% of Cyanco, the financial
statements of Cyanco are not consolidated with the financial statements of the
Company. The Company accounts for its investment in Cyanco using the equity
method of accounting. Equity in earnings of Cyanco is based on the Company's 50%
ownership in Cyanco and is calculated and recognized at the end of each month.
Management fees from Cyanco are recognized monthly and are calculated as a
percentage of Cyanco revenues based on the joint venture agreement. Summarized
financial information for Cyanco is included in Note 11 to the consolidated
financial statements of the Company. See also the separate audited financial
statements of Cyanco included in this report as Exhibit 99.1.
In November 2001, the Company closed the sale of the assets,
subsidiaries and certain joint venture interests of its Explosives Business to
UEE. The sale of the Explosives Business is accounted for as a discontinued
operation, and accordingly, the operating results for the Explosives Business in
the accompanying consolidated financial statements for the year ended December
31, 2001 have been presented as discontinued operations.
The Company's current assets at December 31, 2003 were comprised
primarily of cash and cash equivalents of $6,424,000 and short-term investments
of $5,614,000. Investments with scheduled maturities greater than three months
but not greater than one year are recorded as short-term investments. The
short-term investments are recorded at fair value with net unrealized gains or
losses reported in stockholders' equity. Realized gains and losses are included
in the consolidated statements of operations.
Forward Looking Statements
Within this Annual Report on Form 10-K, including the discussion in
this Item 7, there are forward-looking statements made in an effort to inform
the reader of management's expectation of future events. These expectations are
subject to numerous factors and assumptions, any one of which, could have a
material effect on future results. The factors which may impact future operating
results include, but are not limited to, decisions made by Cyanco's customers as
to the continuation, suspension, or termination of mining activities in the area
served by Cyanco, changes in world supply and demand for commodities,
particularly gold, political, environmental, regulatory, economic and financial
risks, major changes in technology which could affect the mining industry as a
whole or which could affect sodium cyanide specifically, competition, and the
continued availability of qualified technical and other professional employees
of the Company and Cyanco. The Company believes it is taking appropriate actions
in order to address these and other factors previously disclosed; however, some
of the risks are outside the control of the Company, and the actions taken by
the Company may not be sufficient to avoid the adverse consequences of one or
more of the risks. Consequently, the actual results could differ materially from
those indicated in the statements made.
10
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
A significant portion of the Company's cash equivalents and short-term
investments bear variable interest rates that are adjusted to market conditions.
Changes in market rates will affect interest earned on these instruments, and
potentially the carrying value of the investments. However, the Company does not
utilize derivative instruments to offset the exposure to interest rates. The
cash equivalents and short-term investments are placed in a variety of products
with different institutions. Significant changes in interest rates could have a
material impact on the Company's consolidated financial position and results of
operations.
The Company has no foreign operations and is currently not exposed to
material risks from changes in foreign currency.
Item 8. Financial Statements and Supplementary Data.
The financial statements of the Company and of Cyanco required by this
Item are contained in a separate section of this report. See "Index to
Consolidated Financial Statements" on Page F-1 for the consolidated financial
statements of the Company included in this report, and the separate financial
statements of Cyanco included as Exhibit 99.1
The following table presents quarterly financial data for each of the
four quarters in 2003 and 2002. All amounts for 2003 and 2002 are from
continuing operations, since discontinued operations of the Explosives Business
are presented in the accompanying consolidated statements of operations for 2001
only.
Amounts in thousands 2003 2002
(except per share data) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Revenues and equity
in earnings $ 579 $ 486 $ 954 $ 941 $ 472 $ 845 $1,446 $ 1,149
Net income 319 260 578 548 208 676 644 600
Earnings per common
share - diluted $0.04 $0.04 $ 0.08 $ 0.08 $0.03 $0.09 $ 0.09 $ 0.08
Item 9. Changes in and Disagreements with Accountants on Accounting
and Financial Disclosure
None.
Item 9A. Controls and Procedures
(a) Evaluation of disclosure controls and procedures
Based on their evaluations as of December 31, 2003, the principal
executive officer and principal financial officer of the Company have concluded
11
that the Company's disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) under the Securities Exchange Act) are effective to
ensure that information required to be disclosed by the Company in reports that
the Company files or submits under the Securities Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the
rules and forms of the SEC.
(b) Changes in internal controls
There were no significant changes in the Company's internal controls
over financial reporting or in other factors that could significantly affect
these internal controls subsequent to the date of their most recent evaluation,
including any corrective actions with regard to significant deficiencies and
material weaknesses.
PART III
Item 10 Directors and Executive Officers of the Registrant.
The information required by this Item is contained in our 2004
Definitive Proxy Statement under the headings "Election of Directors" and
"Executive Officers," and is incorporated in this report by reference.
Item 11. Executive Compensation
The information required by this Item is contained in our 2004
Definitive Proxy Statement under the heading "Executive Compensation," and is
incorporated in this report by reference.
Item 12. Security Ownership of Certain Beneficial Owners and
Management.
The information required by this Item is contained in our 2004
Definitive Proxy Statement under the heading "Security Ownership of Certain
Beneficial Owners and Management," and is incorporated in this report by
reference.
Item 13. Certain Relationships and Related Transactions.
There are no transactions to report under this Item for the year ended
December 31, 2003.
Item 14. Principal Accountant Fees and Services
The information required by this Item is contained in our 2004
Definitive Proxy Statement under the heading "Ratification of Selection of
Independent Public Accountants," and is incorporated in this report by
reference.
12
PART IV
Item 15. Exhibits, Financial Statement Schedules, and Reports on
Form 8-K.
(a) The following documents are filed as a part of this report:
1. The audited consolidated financial statements of the Company and
the report of independent certified public accountants required in
Part II, Item I are included on pages F-1 to F-21. See the Index
to Consolidated Financial Statements on page F-1.
2. Also included as financial statement schedules to this Annual
Report on Form 10-K as Exhibit 99.1 are the audited financial
statements of Cyanco, a significant subsidiary reported on the
equity method, and the report of independent certified public
accountants.
No other required financial statement schedules are listed
because they are not applicable or the required information is
shown in the Company's financial statements or notes thereto.
3. Exhibits:
3.1 Articles of Amendment and Restatement of the
Articles of Incorporation to restate the articles of
incorporation and to reflect the name change to
Nevada Chemicals, Inc. (Incorporated herein by
reference from Form 10-K filed by the Company for
the fiscal year ended December 31, 2001).
3.2 Bylaws of the Corporation as amended May 19, 1999
(Incorporated herein by reference from the Form
10-K/A filed by the Company for the fiscal year
ended December 31, 2000).
4.1 1988 Nonqualified Stock Option Plan, as amended
through May 19, 1999 (Incorporated by reference from
the Form 10-K filed by the Company for the fiscal
year ended December 31, 1999).
14 Nevada Chemicals, Inc. Code of Ethics and Business
Conduct (this filing).
21 List of Subsidiaries (this filing).
23 Independent Auditors' Consent (this filing).
31.1 Certification of Principal Executive Officer
pursuant to Rule 13a-15(e) of the Securities
Exchange Act of 1934, as amended, as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of
2002 (this filing).
31.2 Certification of Principal Financial Officer
pursuant to Rule 13a-15(e) of the Securities
Exchange Act of 1934, as amended, as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of
2002 (this filing).
32.1 Certification of Principal Executive Officer
pursuant to 18 U.S.C. Section 1350 as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 (this filing).
32.1 Certification of Principal Financial Officer
pursuant to 18 U.S.C. Section 1350 as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 (this filing).
13
99.1 The financial statements for the fiscal year ended
December 31, 2003 of Cyanco, a significant
subsidiary reported on the equity method, and the
report of independent certified public accountants
(this filing).
99.2 Press release dated March 11, 2004 (this filing).
(b) The Company did not file any reports on Form 8-K during the fourth
quarter of the year ended December 31, 2003.
14
SIGNATURES
Pursuant to the requirements of Section 13 or 15 (d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
NEVADA CHEMICALS, INC.
/s/ John T. Day
-------------------------
John T. Day, President
Date: March 11, 2004
Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
Signatures Capacity in Which Signed Date
---------- ------------------------ ----
/s/ Bryan Bagley Chairman of the Board of Directors March 11, 2004
- --------------------
Bryan Bagley
/s/ John T. Day President, Chief Executive Officer March 11, 2004
- -------------------- and Director (Principal Executive
John T. Day Officer)
/s/ James Solomon Director March 11, 2004
- --------------------
James Solomon
/s/ Nathan L. Wade Director March 11, 2004
- --------------------
Nathan L. Wade
/s/ G. Garfield Cook Director March 11, 2004
- --------------------
G. Garfield Cook
/s/ Dennis P. Gauger Chief Financial Officer and Principal March 11, 2004
- -------------------- Accounting Officer
Dennis P. Gauger
15
NEVADA CHEMICALS, INC.
Index to Consolidated Financial Statements
Independent Auditors' Report F-2
Consolidated Balance Sheets F-3
Consolidated Statements of Operations F-4
Consolidated Statements of Stockholders' Equity F-5
Consolidated Statements of Cash Flows F-6
Notes to Consolidated Financial Statements F-7
INDEPENDENT AUDITORS' REPORT
To the Board of Directors and Stockholders
of Nevada Chemicals, Inc.
We have audited the consolidated balance sheets of Nevada Chemicals, Inc. as of
December 31, 2003 and 2002, and the related consolidated statements of
operations, stockholders' equity, and cash flows for the years ended December
31, 2003, 2002 and 2001. These consolidated financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these consolidated financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally accepted
in the United States of America. Those standards require that we plan and
perform the audits to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of Nevada Chemicals,
Inc. as of December 31, 2003 and 2002, and the results of its operations and its
cash flows for the years ended December 31, 2003, 2002 and 2001, in conformity
with accounting principles generally accepted in the United States of America.
TANNER + CO.
Salt Lake City, Utah
March 4, 2004
F-2
NEVADA CHEMICALS, INC.
Consolidated Balance Sheets
December 31
Assets 2003 2002
- ------ ---------------------------------
Current assets:
Cash and cash equivalents $ 6,424,000 $ 6,612,000
Short-term investments 5,614,000 4,026,000
Receivables 94,000 99,000
Prepaid expenses 40,000 41,000
Current portion of notes receivable 221,000 319,000
---------------------------------
Total current assets 12,393,000 11,097,000
Investment in joint venture 12,428,000 12,919,000
Notes receivable 186,000 407,000
Property and equipment, net 29,000 38,000
Other assets 228,000 231,000
---------------------------------
$ 25,264,000 $ 24,692,000
=================================
Liabilities and Stockholders' Equity
- ------------------------------------
Current liabilities - accounts payable and accrued
expenses $ 1,635,000 $ 1,097,000
Deferred income taxes 1,732,000 1,584,000
---------------------------------
Total liabilities 3,367,000 2,681,000
---------------------------------
Commitments and contingencies
Stockholders' Equity:
Common stock, $.001 par value, 500,000,000 shares
authorized, 6,807,919 and 7,059,143 shares issued
and outstanding 7,000 7,000
Capital in excess of par value 3,512,000 4,295,000
Accumulated other comprehensive income (loss) (2,000) 13,000
Retained earnings 18,380,000 17,696,000
---------------------------------
Total stockholders' equity 21,897,000 22,011,000
---------------------------------
$ 25,264,000 $ 24,692,000
=================================
See accompanying notes to consolidated financial statements.
F-3
NEVADA CHEMICALS, INC.
Consolidated Statements of Operations
Years Ended December 31
2003 2002 2001
----------------------------------------------------
Revenues and equity in earnings:
Management fee from joint venture $ 451,000 $ 460,000 $ 443,000
Equity in earnings of joint venture 2,509,000 3,316,000 2,063,000
Other - 136,000 27,000
----------------------------------------------------
Total 2,960,000 3,912,000 2,533,000
General and administrative expenses 639,000 1,256,000 1,015,000
----------------------------------------------------
Operating income from continuing operations 2,321,000 2,656,000 1,518,000
----------------------------------------------------
Other income:
Investment and other income 302,000 270,000 86,000
Gain on sale of assets - 680,000 -
----------------------------------------------------
Total other income 302,000 950,000 86,000
----------------------------------------------------
Income from continuing operations before
provision for income taxes 2,623,000 3,606,000 1,604,000
Provision for income taxes 918,000 1,478,000 597,000
----------------------------------------------------
Income from continuing operations 1,705,000 2,128,000 1,007,000
Discontinued operations:
Loss from discontinued operations of explosives
business, net of income tax benefit of $214,000 - - (365,000)
Loss on disposal of explosives business, including
provision for income taxes of $(301,000) - - (456,000)
----------------------------------------------------
Net income $ 1,705,000 $ 2,128,000 $ 186,000
====================================================
Earnings (loss) per common share - basic:
Continuing operations $ 0.25 $ 0.30 $ 0.14
Discontinued operations - - (0.11)
----------------------------------------------------
$ 0.25 $ 0.30 $ 0.03
====================================================
Earnings (loss) per common share - diluted:
Continuing operations $ 0.24 $ 0.29 $ 0.14
Discontinued operations - - (0.11)
----------------------------------------------------
$ 0.24 $ 0.29 $ 0.03
====================================================
Weighted average number of shares outstanding:
Basic 6,879,000 7,174,000 7,301,000
Diluted 7,016,000 7,327,000 7,333,000
See accompanying notes to consolidated financial statements.
F-4
NEVADA CHEMICALS, INC.
Consolidated Statements of Stockholders' Equity
Years Ended December 31, 2003, 2002 and 2001
Capital Accumulated
Common Stock in Excess Other
------------------ of Par Comprehensive Retained Treasury
Shares Amount Value Income (Loss) Earnings Stock Total
------------------------------------------------------------------------------------------
Balance, January 1, 2001 7,314,260 $ 7,000 $ 5,312,000 $ (456,000) $15,382,000 $ - $ 20,245,000
Comprehensive net income
calculation:
Net income - - - - 186,000 - 186,000
Foreign currency translation
adjustment, net - - - 456,000 - - 456,000
------------
Comprehensive income - - - - - - 642,000
------------
Purchase of treasury stock - - - - - (573,000) (573,000)
------------------------------------------------------------------------------------------
Balance, December 31, 2001 7,314,260 7,000 5,312,000 - 15,568,000 (573,000) 20,314,000
Comprehensive net income
calculation:
Net income - - - - 2,128,000 - 2,128,000
Net unrealized gains
on investments - - - 13,000 - - 13,000
------------
Comprehensive income - - - - - - 2,141,000
------------
Purchase and retirement of
treasury stock (255,117) - (1,017,000) - - 573,000 (444,000)
------------------------------------------------------------------------------------------
Balance, December 31, 2002 7,059,143 7,000 4,295,000 13,000 17,696,000 - 22,011,000
Comprehensive net income
calculation:
Net income - - - - 1,705,000 - 1,705,000
Net unrealized losses
on investments - - - (15,000) - - (15,000)
------------
Comprehensive income - - - - - - 1,690,000
------------
Dividends declared - - - - (1,021,000) (1,021,000)
Purchase and retirement of
treasury stock (251,224) - (783,000) - - - (783,000)
------------------------------------------------------------------------------------------
Balance, December 31, 2003 6,807,919 $ 7,000 $ 3,512,000 $ (2,000) $18,380,000 $ - $ 21,897,000
==========================================================================================
See accompanying notes to consolidated financial statements.
F-5
NEVADA CHEMICALS, INC.
Consolidated Statements of Cash Flows
Years Ended December 31
2003 2002 2001
--------------------------------------------------
Cash flows from operating activities:
Net income $ 1,705,000 $ 2,128,000 $ 186,000
Adjustments to reconcile net income to net cash
used in operating activities:
Depreciation and amortization 11,000 36,000 941,000
Provision for losses on assets - 223,000 -
Loss on sale of discontinued explosives business - - 456,000
Equity in earnings of joint ventures (2,509,000) (3,316,000) (3,276,000)
Gain on sale of assets - (680,000) (223,000)
Recognition of cumulative foreign currency
translation adjustment - - 456,000
Deferred income taxes 148,000 110,000 (580,000)
(Increase) decrease in:
Receivables 5,000 1,243,000 161,000
Inventories - - 94,000
Prepaid expenses 1,000 8,000 (45,000)
Other assets 3,000 14,000 (131,000)
Increase (decrease) in accounts payable
and accrued expenses 197,000 (776,000) 1,170,000
--------------------------------------------------
Net cash used in operating activities (439,000) (1,010,000) (791,000)
--------------------------------------------------
Cash flows from investing activities:
Distributions from joint venture 3,000,000 3,000,000 1,442,000
Proceeds from sale of assets - 1,556,000 253,000
Net cash received from sale of discontinued
explosives business - - 5,203,000
Increase in notes receivable - (1,000,000) -
Payments on notes receivable 319,000 1,489,000 180,000
Purchase of property and equipment (2,000) - (542,000)
Net purchases of short-term investments (1,603,000) (4,013,000) -
--------------------------------------------------
Net cash provided by investing activities 1,714,000 1,032,000 6,536,000
--------------------------------------------------
Cash flows from financing activities:
Proceeds from long-term debt - - 250,000
Payments of long-term debt - - (578,000)
Payments of dividends (680,000) - -
Purchase and retirement of treasury stock (783,000) (421,000) (519,000)
--------------------------------------------------
Net cash used in financing activities (1,463,000) (421,000) (847,000)
--------------------------------------------------
Net increase (decrease) in cash and cash equivalents (188,000) (399,000) 4,898,000
Cash and cash equivalents, beginning of year 6,612,000 7,011,000 2,113,000
--------------------------------------------------
Cash and cash equivalents, end of year $ 6,424,000 $ 6,612,000 $ 7,011,000
==================================================
See accompanying notes to consolidated financial statements.
F-6
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
Note 1: Organization and Significant Accounting Policies
Organization - Nevada Chemicals, Inc. (the "Company"), primarily
through its ownership in Cyanco Company ("Cyanco"), supplies chemicals to the
gold mining industry in the United States. Winnemucca Chemicals, Inc.
("Winnemucca Chemicals"), a wholly owned subsidiary of the Company, has a fifty
percent interest in Cyanco, a non-corporate joint venture engaged in the
manufacture and sale of liquid sodium cyanide. The Company accounts for its
investment in Cyanco using the equity method of accounting. Summarized financial
information for Cyanco is included in Note 11.
In November 2001, the Company closed the sale of the assets,
subsidiaries and certain joint venture interests of its explosives business to
Union Espanola de Explosivos S.A. and certain of its subsidiaries ("UEE"). The
explosives business is accounted for as a discontinued operation in the
consolidated financial statements for 2001.
Principles of Consolidation - The consolidated financial statements
include the accounts of the Company, and its consolidated subsidiaries. All
significant inter-company balances and transactions have been eliminated.
Cash and Cash Equivalents - For purposes of the consolidated statements
of cash flows, cash and cash equivalents includes all cash and investments with
original maturities to the Company of three months or less.
Short-term Investments - Investments with scheduled maturities greater
than three months, but not greater than one year, are recorded as short-term
investments. These investments at December 31, 2003 and 2002 are classified by
management as available for sale. The short-term investments are recorded at
fair value, with net unrealized gains or losses reported in stockholders'
equity. Realized gains and losses are included in the consolidated statements of
operations.
Property and Equipment - Property and equipment are recorded at cost,
less accumulated depreciation. Depreciation is computed using the straight-line
method over the estimated useful lives of the assets. Expenditures for
maintenance and repairs are expensed when incurred and betterments are
capitalized. Gains and losses on the sale of property and equipment are included
in the consolidated statements of operations.
Translation of Foreign Currencies - Prior to the sale of the explosives
business, the cumulative effect of currency translation adjustments was included
in stockholders' equity. These items represent the effect of translating assets
and liabilities of the Company's foreign operations. Subsequent to the sale of
the explosives business, the Company had no material foreign operations.
F-7
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
Revenue Recognition - The Company's revenues and equity in earnings
consist mainly of earnings from Cyanco based on the equity method of accounting
and management fees from Cyanco. Equity in net earnings of Cyanco is based on
the Company's 50% ownership in Cyanco, and is calculated and recognized at the
end of each month. Management fee income from Cyanco is recognized monthly based
on the Cyanco joint venture agreement.
Income Taxes - Deferred income taxes are provided in amounts sufficient
to give effect to temporary differences between financial and tax reporting,
principally related to depreciation and amortization, undistributed earnings
from joint ventures, which qualify under certain tax deferral treatment, and
foreign tax credits.
Stock-Based Compensation - At December 31, 2003, the Company has a
stock-based employee compensation plan, which is described more fully in Note
10. The Company accounts for that plan under the recognition and measurement
principles of APB Opinion No. 25, Accounting for Stock Issued to Employees, and
related interpretations. No stock-based employee compensation cost is reflected
in net income, as all options granted under the plan had an exercise price equal
to or greater than the market value of the underlying common stock on the date
of grant.
The following table illustrates the effect on net income and earnings
per share if the Company applied the fair value recognition provisions of FASB
Statement No. 123, Accounting for Stock-Based Compensation, to stock-based
employee compensation.
Years Ended December 31
2003 2002 2001
---------------------------------------------
Net income as reported $1,705,000 $2,128,000 $ 186,000
Deduct stock-based employee
compensation determined under fair
value based method for all awards,
net of related tax effects - - (76,000)
---------------------------------------------
Net income - pro forma $1,705,000 $2,128,000 $ 110,000
=============================================
Earnings per share:
Basic - as reported $ 0.25 $ 0.30 $ 0.03
Basic - pro forma $ 0.25 $ 0.30 $ 0.02
Diluted - as reported $ 0.24 $ 0.29 $ 0.03
Diluted - pro forma $ 0.24 $ 0.29 $ 0.02
No options were granted in 2003 and 2002.
F-8
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
The fair value of the options granted in 2001 is estimated at the date
of grant using the Black-Scholes option pricing model with the following
assumptions: expected dividend yield of $0; expected stock price volatility of
62%; risk-free interest rate of 4.66%; and expected life of options of 2 years.
The weighted average fair value of options granted during 2001 was $.45.
Earnings Per Common Share - The computation of basic earnings per
common share is based on the weighted average number of shares outstanding
during the year.
The computation of earnings per common share assuming dilution is based
on the weighted average number of shares outstanding during the year plus the
weighted average common stock equivalents which would arise from the exercise of
stock options outstanding using the treasury stock method and the average market
price per share during the year.
The shares used in the computation of the Company's basic and diluted
earnings per share are reconciled as follows:
Years Ended December 31
2003 2002 2001
-----------------------------------------
Weighted average number of shares
outstanding - basic 6,879,000 7,174,000 7,301,000
Dilutive effect of stock options 137,000 153,000 32,000
-----------------------------------------
Weighted average number of shares
outstanding, assuming dilution 7,016,000 7,327,000 7,333,000
=========================================
Concentration of Credit Risk - At December 31, 2003, financial
instruments which potentially subject the Company to concentration of credit
risk consist primarily of cash and cash equivalents, short-term investments and
receivables.
The Company maintains its cash and cash equivalents in bank deposit
accounts which, at times, may exceed federally insured limits. Short-term
investments consist of various investment products placed with a variety of
financial institutions. The Company has not experienced material losses in such
accounts and believes it is not exposed to any significant credit risk on cash
and cash equivalents and short-term investments.
Receivables consist primarily of management fees from Cyanco and
accrued interest on notes receivable. Management does not believe significant
credit risk exists for these receivables at December 31, 2003.
F-9
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
Cyanco's customer base consists primarily of mining companies in the
Western United States. Since most of Cyanco's customers are large mining
companies, the number of companies it services is relatively small compared to
those of a wholesale distribution or retail business. A loss of one or more
customers could adversely affect future sales, and may cause material adverse
effect on Cyanco's results of operations. Although Cyanco is directly affected
by the economic health of the mining industry, management does not believe
significant credit risk exists at December 31, 2003. In addition, Cyanco has
purchase commitments with suppliers of certain raw materials covering various
time periods and containing various pricing arrangements. Management believes
alternative sources of the raw materials are available in the event that the
suppliers are unable to meet Cyanco's raw material needs.
Use of Estimates - The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period. Actual results could
differ from those estimates.
Recent Accounting Pronouncements - In November 2002, the FASB issued
Interpretation No. ("FIN") 45, Guarantor's Accounting and Disclosure
Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of
Others. This interpretation elaborates on the disclosures to be made by a
guarantor in its interim and annual financial statements about its obligations
under guarantees issued. FIN 45 also clarifies that a guarantor is required to
recognize, at inception of a guarantee, a liability for the fair value of the
guarantee. The disclosure requirements are effective for financial statements of
interim or annual periods ending after December 31, 2002. Because the Company
currently is not a guarantor on any indebtedness, the adoption of FIN 45 did not
have any effect on the Company's consolidated financial position or results of
operations.
In December 2003, the FASB issued Interpretation No. 46 ("FIN 46R")
(revised December 2003), Consolidation of Variable Interest Entities, an
Interpretation of Accounting Research Bulletin No. 51 ("ARB 51"), which
addresses how a business enterprise should evaluate whether it has a controlling
interest in an entity through means other than voting rights and accordingly
should consolidate the entity. FIN 46R replaces FASB Interpretation No. 46 (FIN
46), which was issued in January 2003. Before concluding that it is appropriate
to apply ARB 51 voting interest consolidation model to an entity, an enterprise
must first determine that the entity is not a variable interest entity ("VIE").
As of the effective date of FIN 46R, an enterprise must evaluate its involvement
with all entities or legal structures created before February 1, 2003 to
determine whether consolidation requirements of FIN 46R apply to those entities.
There is no grandfathering of existing entities. Public companies must apply
either FIN 46 or FIN 46R immediately to entities created after January 31, 2003
and no later than the end of the first reporting period that ends after March
15, 2004. The adoption of FIN 46 had no effect on the Company's consolidated
financial position, results of operations or cash flows.
F-10
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
In April 2003, the FASB issued SFAS No. 149, "Amendment of Statement
133 on Derivative Instruments and Hedging Activities." The purpose of SFAS 149
is to amend and clarify financial accounting and reporting for derivative and
hedging activities under SFAS 133. SFAS 149 is effective for contracts entered
into or modified after June 30, 2003 and for designated hedging relationships
after June 30, 2003. Since the Company does not currently participate in
derivative and hedging activities, the adoption of SFAS 149 did not have any
effect on the Company's consolidated financial position or results of
operations.
In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain
Instruments With Characteristics of Both Liabilities and Equity." This statement
establishes standards for how an issuer classifies and measures certain
financial instruments with characteristics of both liabilities and equity. It
requires that an issuer classify a financial instrument that is within its scope
as a liability (or an asset in some circumstances). Many of those instruments
were previously classified as equity. The statement was effective on July 1,
2003 for financial instruments entered into or modified after May 31, 2003, and
otherwise effective for existing financial instruments entered into before May
31, 2003. Since the Company does not have any financial instruments within the
scope of this statement, the adoption of SFAS No. 150 did not have any effect on
the Company's consolidated financial position or results of operations.
Reclassifications - Certain amounts in the prior years' financial
statements have been reclassified to conform with the current year presentation.
Note 2: Short-Term Investments
Short-term investments are comprised of the following:
December 31
2003 2002
----------------------------------------------------------------------------
Cost Market Value Cost Market Value
----------------------------------------------------------------------------
Certificates of deposit $ 191,000 $ 189,000 $ 3,884,000 $ 3,897,000
Managed bond funds 2,624,000 2,624,000 - -
U.S. government securities 697,000 697,000 - -
Corporate paper 1,503,000 1,503,000 - -
Other 601,000 601,000 129,000 129,000
----------------------------------------------------------------------------
5,616,000 5,614,000 4,013,000 4,026,000
Net unrealized gains (losses) (2,000) - 13,000 -
----------------------------------------------------------------------------
$ 5,614,000 $ 5,614,000 $ 4,026,000 $ 4,026,000
============================================================================
F-11
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
All short-term investments at December 31, 2003 and 2002 had scheduled
maturities within one year. Net realized losses on short-term investments were
$44,000 for the year ended December 31, 2003. No realized gains or losses on
short-term investments were recorded in 2002 and 2001.
Note 3: Detail of Certain Balance Sheet Accounts
December 31
2003 2002
-------------------------------------
Receivables:
Related party (see Note 9) $ 53,000 $ 52,000
Accrued interest receivable 41,000 47,000
-------------------------------------
$ 94,000 $ 99,000
=====================================
Accounts payable and accrued expenses:
Accounts payable - trade $ 15,000 $ 10,000
Income taxes payable ( see Note 14) 1,243,000 1,040,000
Dividends payable 341,000 -
Other accrued expenses 36,000 47,000
-------------------------------------
$ 1,635,000 $ 1,097,000
=====================================
Note 4: Notes Receivable
Notes receivable are comprised of the following:
December 31
2003 2002
-----------------------------------
Unsecured note receivable
from UEE, due $200,000 in
July 2004 and $186,000 in
July 2005, plus interest
at 8.5% $ 386,000 $ 587,000
Unsecured note receivable
from a subsidiary of UEE, in
monthly installments of $10,000,
including interest at 6.5% 21,000 139,000
-----------------------------------
407,000 726,000
Less current portion 221,000 319,000
-----------------------------------
Long- term portion $ 186,000 $ 407,000
===================================
F-12
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
In connection with the sale of the explosives business, any
receivables, less an agreed upon reserve of $153,000, that had not been
collected within 240 days of the closing date (November 15, 2001) were to be
offset against the note receivable from UEE in the reverse order of maturity.
During 2002, the note receivable from UEE was reduced by $214,000 for net
uncollected notes and accounts receivable assigned back to the Company by UEE.
Bad debt expense of $214,000 was included in general and administrative expenses
for 2002. The Company continues to pursue collection of the assigned
receivables. During 2003, the Company collected $70,000 of the receivables,
which was recorded as a reduction of general and administrative expenses.
Note 5: Property and Equipment
Property and equipment consist of the following:
December 31,
2003 2002
---------------------------------------
Office furniture and fixtures $ 22,000 $ 20,000
Vehicles 34,000 34,000
---------------------------------------
56,000 54,000
Less accumulated depreciation (27,000) (16,000)
---------------------------------------
$ 29,000 $ 38,000
=======================================
Note 6: Gain on Sale of Assets
During 2002, the Company sold its office building for approximately
$1,170,000 and realized a gain of $220,000, which gain is included in gain on
sale of assets in the accompanying consolidated statements of operations.
Also in 2002, the Company and its joint venture partner completed the
sale of the assets of West Coast Explosives Limited, a joint venture in West
Africa. Previously, the Company wrote off its investment in this joint venture,
including a note receivable, due to the joint venture's continuing operating
losses. The Company's share of net cash proceeds from the sale of assets was
approximately $460,000, which gain is included in gain on sale of assets in the
accompanying consolidated statements of operations.
F-13
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
Note 7: Income Taxes
The current provision for income taxes primarily represents U.S.
federal income taxes. The benefit (provision) for income taxes is different than
amounts which would be provided by applying the statutory federal income tax
rate to income from continuing operations before income taxes for the following
reasons:
Years Ended December 31
2003 2002 2001
---------------------------------------------
Federal income tax provision at
statutory rate $(1,023,000) $(1,406,000) $ (593,000)
Life insurance and meals (4,000) 1,000 (4,000)
Tax exempt interest income 33,000 - -
Other 76,000 (73,000) -
-------------------------------------------
$ (918,000) $(1,478,000) $ (597,000)
===========================================
The total income tax benefit (provision) consists of the following:
Years Ended December 31
2003 2002 2001
---------------------------------------------
Current $ (770,000) $(1,368,000) $(1,177,000)
Deferred (148,000) (110,000) 580,000
---------------------------------------------
$ (918,000) $(1,478,000) $ (597,000)
=============================================
Deferred tax assets (liabilities) are comprised of the following:
December 31
2003 2002
------------------------------
Depreciation and amortization $(3,213,000) $(3,117,000)
Foreign tax and other credit carryforwards 1,471,000 1,523,000
Other 10,000 10,000
------------------------------
$(1,732,000) $(1,584,000)
==============================
F-14
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
Note 8: Supplemental Consolidated Statements of Cash Flows Information
Amounts paid for income taxes were $580,000, $470,000, and $508,000 in
2003, 2002 and 2001, respectively. The Company paid no interest in 2003 and
2002, and paid interest of $519,000 in 2001.
During 2003:
o The Company declared a dividend in December, which was paid in
January 2004, increasing accounts payable and accrued expenses and
reducing retained earnings by $341,000.
During 2002:
o The Company retired 102,391 shares of treasury stock acquired in
2001 with a cost of $573,000.
o A note receivable from an officer of $23,000 was repaid by receipt
by the Company of 5,709 shares of the Company's common stock
valued at $23,000, which stock was subsequently retired.
During 2001:
o The Company reclassified accounts receivable of $229,000 to a note
receivable due from UEE.
o The Company reclassified interest receivable of $110,000, which
was previously recorded as part of a note receivable from UEE, to
accounts receivable.
o In connection with the sale of its explosives business, the
Company repurchased common stock from a former officer in exchange
for partial repayment of a note receivable of $54,000.
o The Company paid certain accrued expenses to an officer in
exchange for forgiveness of a note receivable of $6,000.
o The Company sold equipment to a joint venture in exchange for
accounts receivable of $125,000.
F-15
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
o As described in Note 15, the Company sold its explosives business
to UEE in 2001. The following table summarizes the assets and
liabilities sold, consideration received, and loss recognized on
the sale:
Assets Sold and Liabilities Assumed by UEE
Receivables, net $ 6,468,000
Inventories 2,154,000
Other current assets 208,000
Investments in and advances to joint ventures 2,117,000
Property and equipment, net 6,143,000
Notes receivable from joint ventures 1,070,000
Other assets 279,000
Accounts payable and accrued expenses (7,340,000)
Notes payable (6,278,000)
------------
Net assets sold 4,821,000
Consideration Received
Notes receivable and accrued interest received 1,310,000
Net cash received (net of $1,147,000 sold) 5,203,000
------------
Gain before expenses of sale and income tax
effect 1,692,000
Expenses directly related to the sale (1,847,000)
Provision for income taxes (301,000)
------------
Loss recognized on sale $ (456,000)
============
Note 9: Related Party Transactions
The Company performs certain management functions for Cyanco for which
it receives a fee. Management fees totaled $451,000, $460,000 and $443,000 for
2003, 2002 and 2001, respectively.
At December 31, 2003 and 2002, the Company had receivables of $53,000
and $52,000, respectively, due from Cyanco.
During 2002, the Company paid $103,000 each to two board members for
services and the directors' surrender of all their outstanding stock options.
F-16
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
During 2002, a note receivable from an officer of $23,000 was repaid
through the transfer to the Company of 5,709 shares of the Company's common
stock. The indebtedness was repaid with the shares at their current market value
in accordance with the terms of the original note agreement.
As compensation for services rendered in connection with the sale of
the explosives business in November 2001, the Company agreed to pay $160,000 and
$103,000 to two former board members. $50,000 was paid to one former board
member in 2001, with the remaining amounts paid to the board members in January
2002.
Note 10: Non-Qualified Stock Option Plan
Under the 1988 Non-Qualified Stock Option Plan (the Option Plan), as
amended, a maximum of 1,315,130 shares were made available for granting of
options to purchase common stock at prices generally not less than the fair
market value of common stock at the date of grant. Under the Option Plan, grants
of non-qualified options may be made to selected officers and key employees
without regard to any performance measures. The options may be immediately
exercisable or may vest over time as determined by the board of directors.
However, the maximum term of an option may not exceed ten years. Options may not
be transferred except by reason of death, with certain exceptions, and
termination of employment accelerates the expiration date of any outstanding
options to 30 days from the date of termination.
In connection with the sale of the explosives business to UEE in
November 2001, substantially all employees terminated their employment with the
Company and surrendered to the Company all previously issued stock options. The
Company's President and CEO and continuing members of the board of directors
retained their stock options.
F-17
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
Information regarding the Option Plan is summarized below:
Number of Option Price
Options per Share
---------------------------------------
Outstanding at January 1, 2001 728,747 $1.38 - 11.30
Granted 170,000 1.21
Exercised - -
Expired / forfeited (521,247) 1.38 - 11.30
---------------------------------------
Outstanding at December 31, 2001 377,500 1.21 - 2.31
Granted - -
Exercised - -
Expired / forfeited (159,000) 1.21 - 1.44
---------------------------------------
Outstanding at December 31, 2002 218,500 1.21 - 2.31
Granted - -
Exercised - -
Expired / forfeited (10,000) 2.31
---------------------------------------
Outstanding at December 31, 2003 208,500 $1.21 - 1.44
=======================================
Options exercisable and available for future grant are as follows:
December 31
2003 2002 2001
------------------------------------------
Options exercisable 208,500 218,500 377,500
Options available for grant 614,207 604,207 445,207
The following table summarizes information about stock options
outstanding at December 31, 2003:
Options Outstanding Options Exercisable
--------------------------------------------------------------------
Weighted
Average Weighted Weighted
Range of Number Remaining Average Number Average
Exercise Outstanding Contractual Exercise Exercisable Exercise
Prices At 12/31/03 Life (Years) Price At 12/31/03 Price
- --------------------------------------------------------------------------------
$ 1.44 118,500 1.59 $ 1.44 118,500 $ 1.44
1.21 90,000 2.89 1.21 90,000 1.21
F-18
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
Note 11: Significant Unconsolidated Affiliate
The Company accounts for its 50% ownership interest in Cyanco using
the equity method of accounting. Summarized financial information of Cyanco, a
significant unconsolidated affiliate of the Company, is as follows:
Year Ended December 31
2003 2002 2001
------------------------------------------
Results for the year:
Gross revenues $ 30,117,000 $ 30,632,000 $ 29,767,000
Gross profit 7,221,000 8,757,000 5,905,000
Net income 5,016,000 6,632,000 4,126,000
Company's 50% equity in earnings $ 2,509,000 $ 3,316,000 $ 2,063,000
Year-end financial position:
Current assets $ 7,244,000 $ 6,613,000
Non-current assets 18,782,000 20,133,000
Current liabilities 3,100,000 2,525,000
Non-current liabilities 247,000 558,000
Note 12: Profit Sharing Plan
The Company has a defined contribution profit sharing plan, which is
qualified under Section 401 (K) of the Internal Revenue Code. The plan provides
retirement benefits for employees meeting minimum age and service requirements.
Participants may contribute a percentage of their gross wages, subject to
certain limitations. The plan provides for discretionary matching contributions,
as determined by the board of directors, to be made by the Company. The
discretionary amount contributed to the plan by the Company was $5,000, $4,000
and $106,000 for 2003, 2002 and 2001, respectively.
Note 13: Fair Value of Financial Instruments
The Company's financial instruments consist of cash and cash
equivalents, short-term investments, receivables, notes receivable and accounts
payable. The carrying amount of cash, receivables and accounts payable
approximates fair value because of the short-term nature of these items. The
carrying amount of short-term investments is based on market prices. The
carrying amount of notes receivable approximates fair value as the individual
borrowings bear interest which approximate market rates for similar instruments.
F-19
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
Note 14: Commitments and Contingencies
Foreign Income Taxes - The Company has retained all contingent
liabilities relating to an ongoing audit by the Canada Customs and Revenue
Agency ("CCRA") of previously filed income tax returns in Canada. To date, CCRA
has taken a different position on certain matters than that taken by the
Company. The Company, based on consultation with its professional tax advisors
in Canada, believes that the facts and circumstances support the position taken
by the Company, and continues discussions and negotiations with CCRA. The
Company believes that amounts accrued and included in income taxes payable at
December 31, 2003 will be adequate for the resolution of the audit by CCRA.
However, there can be no assurance that such costs will not ultimately exceed
the current estimate.
Litigation - The Company may be subject to legal proceedings arising
out of the normal conduct of its business, which the Company believes will not
materially affect its financial position or results of operations.
Note 15: Sale of Explosives Business
The Company completed the sale of its explosives business to UEE on
November 15, 2001. As a result, the explosives business is accounted for as a
discontinued operation, and accordingly, amounts in the consolidated financial
statements and related notes for 2001 have been presented to reflect
discontinued operations accounting. Summarized operating results of the
explosives business are shown in the table below.
As consideration for the explosives business, subject to certain
adjustments, (i) the Company received $6.35 million cash; (ii) UEE and its
subsidiaries assumed notes and accrued interest payable to the Company totaling
approximately $1.3 million, the first of which, in the principal amount of $1.0
million is payable in equal annual installments over five years beginning in
July of 2002, and the second of which, in the principal amount of $200,000, was
paid in January 2002; (iii) UEE assumed essentially all of the Company's
liabilities associated with the explosives business in the approximate amount of
$13.6 million. Expenses of the sale were approximately $1.8 million, including
$431,000 recognition of foreign currency translation adjustment. After giving
effect to an estimated $301,000 income tax provision from the sale, the Company
recognized a loss from the sale of $456,000.
F-20
NEVADA CHEMICALS, INC.
Notes to Consolidated Financial Statements
(Continued)
Operating results of the disposed explosives business in 2001were as
follows:
Revenues $ 36,945,000
---------------
Costs and expenses:
Cost of sales 34,099,000
General and administrative expenses 3,123,000
Other expenses 302,000
---------------
37,524,000
---------------
Loss before income taxes (579,000)
Income tax benefit 214,000
---------------
Net loss $ (365,000)
===============
As part of the sale of the explosives business, the Company purchased a
total of 101,191 shares of its common stock from certain of its former officers
and employees for total consideration of $571,000. These common shares were
retired in 2002.
Note 16: Dividends
During 2003, the Company declared dividends of $.05 per share on a
total of 6,807,919 outstanding shares for each of the second, third and fourth
calendar quarters, for an aggregate of approximately $1,021,000. The dividends
for the second and third quarters were paid in cash, with dividends payable of
$341,000 for the fourth quarter included in accounts payable and accrued
expenses in the accompanying consolidated balance sheet at December 31, 2003.
These dividends payable were paid in January 2004.
F-21